Clinical characteristics | All patients (n = 130) | Weaning success (n = 86) | Weaning failure (n = 44) | P valuea |
---|---|---|---|---|
Age (years) | 69 (60–76) | 68 (59–76) | 70 (63–75) | 0.609c |
Gender (male) | 82 (63.1) | 59 (68.8) | 23 (52.3) | 0.069d |
Body mass index (kg/m2) | 27.9 (± 6.9) | 27.3 (± 6.6) | 29.1 (± 7.4) | 0.369c |
Obesity (BMI ≥ 30 kg/m2) | 40 (30.8) | 24 (27.9) | 16 (36.4) | 0.325d |
Smoking history | 48 (36.9) | 21 (24.5) | 27 (61.4) | < 0.001d |
APACHE-II (points) | 15.9 (± 5.3) | 15.8 (± 5.3) | 15.9 (± 5.4) | 0.905b |
Albumin (g/dL) | 2.2 (± 0.5) | 2.2 (± 0.6) | 2.2 (± 0.5) | 0.338c |
Ventilator days on admission | 25 (16–34) | 27 (17–35) | 23 (16–30) | 0.123c |
Time from Intubation to tracheostomy (days) | 12 (7–18) | 13 (7–19) | 10 (6–15) | 0.057c |
ECLA | 14 (10.8) | 13 (15.1) | 1 (2.3) | 0.026d |
Reason for mechanical ventilation | ||||
Pneumonia | 51 (39.2) | 31 (36.0) | 20 (45.5) | 0.300d |
SARS-CoV-2 infection | 4 (3.1) | 4 (4.7) | 0 (0.0) | – |
Surgery | 32 (24.6) | 25 (29.1) | 7 (15.9) | 0.101d |
Cardiopulmonary resuscitation | 10 (7.7) | 8 (9.3) | 2 (4.5) | 0.337d |
Acute exacerbation of COPD | 10 (7.7) | 2 (2.3) | 8 (18.2) | 0.001d |
Acute heart failure | 6 (4.6) | 5 (5.8) | 1 (2.3) | 0.663e |
Sepsis (including septic shock) | 7 (5.4) | 5 (5.8) | 2 (4.5) | 1.000e |
Other | 17 (13.1) | 10 (11.6) | 7 (15.9) | 0.495d |
Comorbidities | ||||
Charlson comorbidity index (points) | 5.5 (± 2.3) | 5.4 (± 2.4) | 5.6 (± 2.1) | 0.611c |
Renal insufficiency | 46 (35.4) | 36 (41.9) | 10 (22.7) | 0.032d |
Hemodialysis | 24 (18.5) | 21 (24.4) | 3 (6.8) | 0.289d |
Diabetes mellitus | 35 (26.9) | 20 (23.3) | 15 (34.1) | 0.189d |
Coronary artery disease | 33 (25.4) | 23 (26.7) | 10 (22.7) | 0.620d |
COPD | 30 (23.1) | 5 (5.8) | 25 (56.8) | < 0.001d |
Chronic heart failure | 17 (13.1) | 14 (16.3) | 3 (6.8) | 0.132d |
Malignancy | 10 (7.7) | 7 (8.1) | 3 (6.8) | 0.790d |
Hepatopathy | 7 (5.4) | 5 (5.8) | 2 (4.5) | 1.000e |
Interstitial lung disease | 8 (6.2) | 6 (7.0) | 2 (4.5) | 0.716e |